#	Pagina
attuale pagina	/open-h2020/projects/194075/index.html

Opendata, web and dolomites

m-RESIST

Mobile Therapeutic Attention for Patients with Treatment Resistant Schizophrenia

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

m-RESIST project word cloud

Explore the words cloud of the m-RESIST project. It provides you a very rough idea of what is the project "m-RESIST" about.

ultra relapses psychologists care hospitalizations persistent schizophrenia healthy collaborative involve medical 2002 kennedy union point 20 treatment solution actively caregivers symptoms extensive et monitor decision suffering patients periods psychiatrist procedure resist active mueser mortality proportion professionals strategies benefits nature self habits personalised mhealth reduce symptomatology approximately suffer population 50 people patient treating million involvement helps resistant validate disorders risk engaging somatic team participation excess adherence 2013 total morbidity demonstrated illness psychotic al health comorbidities spent addictions hospital therapeutic severity positive tool caregiver intervention complications episodes acceptance

Project "m-RESIST" data sheet

The following table provides information about the project.

Coordinator	FUNDACIO TICSALUT Organization address address: C ERNEST LLUCH 32 Planta 6 Porta 4 TECNOCAMPUS MATARO MARESME TORRE TCM 3 city: MATARO BARCELONA postcode: 8302 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Spain [ES]
Project website	http://www.mresist.eu
Total cost	4˙034˙222 €
EC max contribution	4˙034˙222 € (100%)
Programme	1. H2020-EU.3.1.4. (Active ageing and self-management of health)
Code Call	H2020-PHC-2014-single-stage
Funding Scheme	RIA
Starting year	2015
Duration (year-month-day)	from 2015-01-01 to 2017-12-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	FUNDACIO TICSALUT FUNDACIO TICSALUT Organization address address: C ERNEST LLUCH 32 Planta 6 Porta 4 TECNOCAMPUS MATARO MARESME TORRE TCM 3 city: MATARO BARCELONA postcode: 8302 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	ES (MATARO BARCELONA)	coordinator	366˙250.00
2	INTERUNIVERSITAIR MICRO-ELECTRONICA CENTRUM INTERUNIVERSITAIR MICRO-ELECTRONICA CENTRUM Organization address address: KAPELDREEF 75 city: LEUVEN postcode: 3001 website: www.imec.be contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	BE (LEUVEN)	participant	606˙250.00
3	The Gertner Institute for Epidemiology & Health Policy Research, Ltd The Gertner Institute for Epidemiology & Health Policy Research, Ltd Organization address address: Chaim Sheba Medical Center, Tel Hashomer city: Ramat Gan postcode: 52621 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	IL (Ramat Gan)	participant	532˙875.00
4	IBM GLOBAL SERVICES ESPANA SA IBM GLOBAL SERVICES ESPANA SA Organization address address: CALLE MAR ADRIATICO 2 city: MADRID postcode: 28850 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	ES (MADRID)	participant	422˙875.00
5	FUNDACIO PRIVADA INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU FUNDACIO PRIVADA INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU Organization address address: CALLE SANT ANTONI M CLARET 167 city: BARCELONA postcode: 8025 website: www.santpau.cat contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	ES (BARCELONA)	participant	348˙927.00
6	ATHENS TECHNOLOGY CENTER ANONYMI BIOMICHANIKI EMPORIKI KAI TECHNIKI ETAIREIA EFARMOGON YPSILIS TECHNOLOGIAS ATHENS TECHNOLOGY CENTER ANONYMI BIOMICHANIKI EMPORIKI KAI TECHNIKI ETAIREIA EFARMOGON YPSILIS TECHNOLOGIAS Organization address address: RIZAREIOU 10 city: ATHINA postcode: 152 33 website: www.atc.gr contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	EL (ATHINA)	participant	334˙375.00
7	AB.ACUS SRL AB.ACUS SRL Organization address address: VIA FRANCESCO CARACCIOLO 77 city: MILANO postcode: 20155 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	IT (MILANO)	participant	294˙875.00
8	PARC SANITARI SANT JOAN DE DEU PARC SANITARI SANT JOAN DE DEU Organization address address: CALLE DOCTOR ANTONI PUJADAS 42 city: SANT BOI DE LLOBREGAT postcode: 8830 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	ES (SANT BOI DE LLOBREGAT)	participant	289˙543.00
9	INSTITUTE OF COMMUNICATION AND COMPUTER SYSTEMS INSTITUTE OF COMMUNICATION AND COMPUTER SYSTEMS Organization address address: Patission Str. 42 city: ATHINA postcode: 10682 website: www.iccs.gr contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	EL (ATHINA)	participant	279˙125.00
10	OULUN YLIOPISTO OULUN YLIOPISTO Organization address address: PENTTI KAITERAN KATU 1 city: OULU postcode: 90014 website: www.oulu.fi contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	FI (OULU)	participant	232˙250.00
11	SEMMELWEIS EGYETEM SEMMELWEIS EGYETEM Organization address address: ULLOI UTCA 26 city: BUDAPEST postcode: 1085 website: www.sote.hu contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	HU (BUDAPEST)	participant	173˙500.00
12	AGENCIA DE QUALITAT I AVALUACIO SANITARIES DE CATALUNYA AGENCIA DE QUALITAT I AVALUACIO SANITARIES DE CATALUNYA Organization address address: CALLE ROC BORONAT 81 95 2 PISO city: BARCELONA postcode: 8005 website: www.aatrm.net contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	ES (BARCELONA)	participant	153˙375.00
13	IMINDS IMINDS Organization address address: TECHNOLOGIEPARK 19 city: GENT postcode: 9052 website: www.ibbt.be contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	BE (GENT)	participant	0.00

Map

Project objective

In European Union approximately 5 million people suffer from psychotic disorders. Between 30-50% can be considered resistant to treatment, and 10-20% ultra-resistant. These patients present persistent positive symptomatology, require extensive periods of hospital care, and have a greater risk of excess mortality and multi-morbidity. In addition, a high proportion of the total cost for treating schizophrenia is spent on this population (Kennedy et al., 2013). Intervention strategies based on mHealth have demonstrated their ability to support and promote self-management-based strategies. Evidence from studies point to the importance of engaging patients actively in their own treatment. This active role helps to improve adherence to treatment, and to reduce persistent symptoms severity, relapses and hospitalizations (Mueser et al., 2002). m-RESIST aims to develop an intervention programme based on mHealth to allow patients suffering from resistant schizophrenia to self-manage their condition (resistant schizophrenia and its associated comorbidities, e.g. somatic disorders and addictions). This may facilitate acceptance and involvement of patients with their own treatment, as well as of caregivers. Moreover this programme could provide a new tool to the psychiatrist, psychologists working together with other health care professionals, to better monitor patients, through a personalised and optimised therapeutic process. m-resist will (1) develop and validate an mHealth solution aimed to reduce the severity of episodes and further complications; (2) involve and promote participation of patients and caregivers in the therapeutic process increasing the awareness of patient and caregiver about the nature of the illness and its consequences, benefits of treatment and needs for healthy habits and promoting an active and collaborative role with the medical team in the treatment decision-making procedure.

Deliverables

List of deliverables.
Lessons learned, guidelines and requirements for future deployment of m-RESIST	Documents, reports	2019-02-22 13:10:58
m-RESIST prototype V0	Demonstrators, pilots, prototypes	2019-02-22 13:10:53
m-RESIST website	Websites, patent fillings, videos etc.	2019-02-22 13:10:50
m-RESIST prototype V1	Demonstrators, pilots, prototypes	2019-03-06 09:59:23
Final Project Report including Overall Assessment	Documents, reports	2019-02-25 12:36:10

Take a look to the deliverables list in detail: detailed list of m-RESIST deliverables.

Publications

List of publications.
year	authors and title	journal	last update
2016	J. Seppala, H. Korpela, E. JÃ¤Ã¤skelÃ¤inen, J. Miettunen, M. Isohanni, J. Auvinen, T. NordstrÃ¶m, R. Marttila, S. KeinÃ¤nen-Kiukaanniemi, M.R. JÃ¤rvelin, H. Salo, N. Rautio Somatic comorbidity and its outcomes in schizophrenia during lifespan published pages: S35-S36, ISSN: 0924-9338, DOI: 10.1016/j.eurpsy.2016.01.870	European Psychiatry 33	2019-05-29
2016	Nina Rautio, Juha KÃ¤kelÃ¤, Tanja NordstrÃ¶m, Jouko Miettunen, Sirkka KeinÃ¤nen-Kiukaanniemi, Leena Ala-Mursula, Jaro Karppinen, Matti PenttilÃ¤, Erika JÃ¤Ã¤skelÃ¤inen Prognosis of schizophrenia spectrum disorder may not be predetermined during early development â€“ the Northern Finland Birth Cohort 1966 published pages: 62-68, ISSN: 0920-9964, DOI: 10.1016/j.schres.2016.02.038	Schizophrenia Research 173/1-2	2019-05-29
2016	K. Rubinstein Treatment-resistant schizophrenia during life spanÂ : Epidemiology, outcomes and innovative M-Health treatments within M-RESIST Project published pages: S35, ISSN: 0924-9338, DOI: 10.1016/j.eurpsy.2016.01.869	European Psychiatry 33	2019-05-29
2016	A. SeppÃ¤lÃ¤, J. Miettunen, N. Hirvonen, M. Isohanni, J. Moilanen, H. Koponen, J. SeppÃ¤lÃ¤, E. JÃ¤Ã¤skelÃ¤inen What do we know about treatment-resistant schizophrenia?Â â€“Â A systematic review published pages: S586, ISSN: 0924-9338, DOI: 10.1016/j.eurpsy.2016.01.2175	European Psychiatry 33	2019-05-29
2017	A. SeppÃ¤lÃ¤, J. Miettunen, M. Isohanni, A. Ahmed, E. Grasa, I. Corripio, H. Koponen, J. SeppÃ¤lÃ¤ ,E. JÃ¤Ã¤skelÃ¤inen Kinga Farkas Iluminada Corripio 6th European Conference on Schizophrenia Research: Advancing Researchâ€”Promoting Recovery published pages: 1-108, ISSN: 0940-1334, DOI: 10.1007/s00406-017-0824-8	European Archives of Psychiatry and Clinical Neuroscience 267/S1	2019-05-29
2016	Annika SeppÃ¤lÃ¤, Conrad Molins, Jouko Miettunen, Noora Hirvonen, Iluminada Corripio, Teija Juola, Matti Isohanni, Hannu Koponen, Jani Moilanen, Jussi SeppÃ¤lÃ¤, Erika JÃ¤Ã¤skelÃ¤inen and m-RESIST GROUP What do we know about treatment-resistant schizophrenia? A systematic review. published pages: , ISSN: 0079-7227, DOI:	Psychiatria Fennica 2016 47	2019-05-29
2017	M. Bulgheroni Emerging sensor-based m-health interventions in the assessment of psychotic symptoms published pages: S67, ISSN: 0924-9338, DOI: 10.1016/j.eurpsy.2017.01.071	European Psychiatry 41	2019-05-29
2017	Elena Huerta Ramos, Silvia MarcÃ³ GarcÃa, Maria Soledad Escobar Villegas, Elena Rubio Abadal, Susana Ochoa, Eva Grasa Bello, Anna Alonso SolÃs, Mireia Rabella, JesÃºs Berdun, Margarita Hospedales, Group m-RESIST, Iluminada Corripio Collado, Judith Usall i RodiÃ© m-RESIST, una soluciÃ³n m-Health integral para personas con Esquizofrenia Resistente estudio cualitativo de necesidades y aceptabilidad de usuarios en el Ã¡rea de Barcelona[1] published pages: , ISSN: 1139-9287, DOI:	Actas EspaÃ±olas de PsiquiatrÃa 45(6)	2019-05-29
2017	Johanna Immonen, Erika JÃ¤Ã¤skelÃ¤inen, Hanna Korpela, Jouko Miettunen Age at onset and the outcomes of schizophrenia: A systematic review and meta-analysis published pages: 453-460, ISSN: 1751-7885, DOI: 10.1111/eip.12412	Early Intervention in Psychiatry 11/6	2019-05-29
2017	K. Rubinstein Identifying service and care needs from the usersâ€™ perspective in treatment-resistant schizophrenia published pages: S68, ISSN: 0924-9338, DOI: 10.1016/j.eurpsy.2017.01.072	European Psychiatry 41	2019-05-29
2016	Elena Huerta-Ramos, Maria Soledad Escobar-Villegas, Katya Rubinstein, Zsolt Szabolcs Unoka, Eva Grasa, Margarita Hospedales, Erika JÃ¤Ã¤skelÃ¤inen, Elena Rubio-Abadal, Asaf Caspi, IstvÃ¡n Bitter, Jesus Berdun, Jussi SeppÃ¤lÃ¤, Susana Ochoa, Kata Fazekas, Iluminada Corripio, Judith Usall Measuring Usersâ€™ Receptivity Toward an Integral Intervention Model Based on mHealth Solutions for Patients With Treatment-Resistant Schizophrenia (m-RESIST): A Qualitative Study published pages: e112, ISSN: 2291-5222, DOI: 10.2196/mhealth.5716	JMIR mHealth and uHealth 4/3	2019-05-29
2017	Juha KÃ¤kelÃ¤, Riikka Marttila, Emmi Keskinen, Juha Veijola, Matti Isohanni, Heli Koivumaa-Honkanen, Marianne Haapea, Erika JÃ¤Ã¤skelÃ¤inen, Jouko Miettunen Association between family history of psychiatric disorders and long-term outcome in schizophrenia â€“ The Northern Finland Birth Cohort 1966 study published pages: 16-22, ISSN: 0165-1781, DOI: 10.1016/j.psychres.2016.12.040	Psychiatry Research 249	2019-05-29
2017	I. Corripio m-RESIST project as an example of m-health approach in schizophrenia: Content, aims and realization published pages: S68, ISSN: 0924-9338, DOI: 10.1016/j.eurpsy.2017.01.073	European Psychiatry 41	2019-05-29
2017	Nina Rautio, Jouko Miettunen, Erika JÃ¤Ã¤skelÃ¤inen, Tanja NordstrÃ¶m, Matti Isohanni, Jussi SeppÃ¤lÃ¤ Do adverse perinatal events predict mortality in schizophrenia during midlife? published pages: 23-29, ISSN: 0920-9964, DOI: 10.1016/j.schres.2016.09.031	Schizophrenia Research 179	2019-05-29
2016	C. Molins, A. RoldÃ¡n, I. Corripio, M. Isohanni, J. Miettunen, J. SeppÃ¤lÃ¤, A. SeppÃ¤lÃ¤, H. Koponen, J. Moilanen, E. JÃ¤Ã¤skelÃ¤inen Response to antipsychotic drugs in treatment-resistant schizophrenia: Conclusions based on systematic review published pages: 64-67, ISSN: 0920-9964, DOI: 10.1016/j.schres.2016.09.016	Schizophrenia Research 178/1-3	2019-05-29
2017	J. Seppala, J. Miettunen, E. JÃ¤Ã¤skelÃ¤inen, M. Isohanni, A. SeppÃ¤lÃ¤, H. Koponen Definition, epidemiology, clinical course and outcomes in treatment-resistant schizophrenia published pages: S67, ISSN: 0924-9338, DOI: 10.1016/j.eurpsy.2017.01.070	European Psychiatry 41	2019-05-29

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "M-RESIST" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "M-RESIST" are provided by the European Opendata Portal: CORDIS opendata.